These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 832656)

  • 1. Distribution of pentobarbital and diphenylhydantoin between plasma and cells in blood: effect of salicylic acid, temperature and total drug concentration.
    Ehrnebo M; Odar-Cederlöf I
    Eur J Clin Pharmacol; 1977; 11(1):37-42. PubMed ID: 832656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of amobarbital, pentobarbital and diphenylhydantoin to blood cells and plasma proteins in healthy volunteers and uraemic patients.
    Ehrnebo M; Odar-Cederlöf I
    Eur J Clin Pharmacol; 1975 Aug; 8(6):445-53. PubMed ID: 1233247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of 14-C-salicylic acid and 14-C-pentobarbital to plasma proteins of several species during the perinatal period.
    Short CR; Sexton RL; McFarland K
    Biol Neonate; 1975; 26(1-2):58-66. PubMed ID: 50090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired plasma protein binding of phenytoin in uremia and displacement effect of salicylic acid.
    Odar-Cederlöf I; Borga O
    Clin Pharmacol Ther; 1976 Jul; 20(1):36-47. PubMed ID: 1277724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma protein binding of salicylic acid, phenytoin, chlorpromazine, propranolol and pethidine using equilibrium dialysis and ultracentrifugation.
    Verbeeck RK; Cardinal JA
    Arzneimittelforschung; 1985; 35(6):903-6. PubMed ID: 4026915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of age and sex on the plasma binding of acidic and basic drugs.
    Verbeeck RK; Cardinal JA; Wallace SM
    Eur J Clin Pharmacol; 1984; 27(1):91-7. PubMed ID: 6489431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of fluvastatin to blood cells and plasma proteins.
    Tse FL; Nickerson DF; Yardley WS
    J Pharm Sci; 1993 Sep; 82(9):942-7. PubMed ID: 8229693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma protein binding, plasma concentrations, and effects of diphenylhydantoin in man.
    Lund L; Lunde PK; Rane A; Borga O; Sjöqvist F
    Ann N Y Acad Sci; 1971 Jul; 179():723-8. PubMed ID: 4998913
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of sodium valproate on plasma protein binding of diphenylhydantoin.
    Patsalos PN; Lascelles PT
    J Neurol Neurosurg Psychiatry; 1977 Jun; 40(6):570-4. PubMed ID: 20483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma protein binding interaction between phenytoin and valproic acid in vitro.
    Monks A; Boobis S; Wadsworth J; Richens A
    Br J Clin Pharmacol; 1978 Dec; 6(6):487-92. PubMed ID: 365209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of salicylic acid on the plasma protein binding and pharmacokinetics of misoprostol acid.
    Cook CS; Schoenhard GL; Karim A
    J Pharm Sci; 1994 Jun; 83(6):883-6. PubMed ID: 9120826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of salicylic acid on pharmacokinetics of free and plasma protein-bound bilirubin in experimental unconjugated hyperbilirubinemia.
    Oie S; Levy G
    J Pharm Sci; 1979 Jan; 68(1):1-6. PubMed ID: 758439
    [No Abstract]   [Full Text] [Related]  

  • 13. Decreased binding of drugs and dyes to plasma proteins from rats with acute renal failure: effects of ureter ligation and intramuscular injection of glycerol.
    Bowmer CJ; Lindup WE
    Br J Pharmacol; 1979 Jun; 66(2):275-81. PubMed ID: 465881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of heparin or salicylate infusion on serum protein binding and on concentrations of phenytoin in serum, brain and cerebrospinal fluid of rats.
    Chou RC; Levy G
    J Pharmacol Exp Ther; 1981 Oct; 219(1):42-8. PubMed ID: 7288614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma albumin concentration and diphenylhydantoin binding in man.
    Porter RJ; Layzer RB
    Arch Neurol; 1975 May; 32(5):298-303. PubMed ID: 237499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of diphenylhydantoin (DPH) and tolbutamide in man.
    Wesseling H; Mols-Thürkow I
    Eur J Clin Pharmacol; 1975; 8(1):75-8. PubMed ID: 1233204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of haematocrit, plasma protein concentration and temperature of drug-containing blood in-vitro on the concentrations of the drug in the plasma.
    Tamura A; Sugimoto K; Sato T; Fujii T
    J Pharm Pharmacol; 1990 Aug; 42(8):577-80. PubMed ID: 1981587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug interactions involving aspirin (acetylsalicylic acid) and salicylic acid.
    Miners JO
    Clin Pharmacokinet; 1989 Nov; 17(5):327-44. PubMed ID: 2573442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproic acid: in vitro plasma protein binding and interaction with phenytoin.
    Cramer JA; Mattson RH
    Ther Drug Monit; 1979; 1(1):105-16. PubMed ID: 121944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in plasma protein binding of drugs after blood collection from pregnant rats.
    Chou RC; Levy G
    J Pharm Sci; 1982 Apr; 71(4):471-3. PubMed ID: 7086665
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.